Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019-05-16 00:38 | 2019-05-13 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director, Officer, 10% owner - Chief Executive Officer | Pharmaceutical Preparations | BUY | $4.40 | 838,482 | $3,688,063 | 846,019 | +11,124.9% |
| 2019-05-16 00:36 | 2019-05-13 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director, Officer, 10% owner - Chief Executive Officer | Pharmaceutical Preparations | BUY | $4.40 | 1,257,727 | $5,532,112 | 145,395 | +100.0% |
| 2019-05-15 04:53 | 2019-05-10 | N/A | Runway Growth Finance Corp. | Retirement Plan of Carilion Clinic | 10% owner | Other | BUY | $15.16 | 293,572 | $4,450,548 | 1,739,837 | +20.3% |
| 2019-05-15 00:28 | 2019-05-10 | INOV | N/A | Dunleavy Keith R | Director, Officer, 10% owner - CEO and Chairman of the Board | Other | BUY | $13.41 | 136,995 | $1,836,952 | 536,995 | +34.2% |
| 2019-05-15 04:15 | 2019-05-13 | AFIN | N/A | Kabnick Lisa | Director | Other | BUY | $10.43 | 100,000 | $1,042,790 | 100,000 | +100.0% |
| 2019-05-14 18:21 | 2019-05-10 | N/A | Runway Growth Finance Corp. | OCM Growth Holdings LLC | Director, 10% owner | Other | BUY | $15.16 | 1,628,366 | $24,686,033 | 9,650,423 | +20.3% |
| 2019-05-15 00:00 | 2019-05-10 | NMRK | NEWMARK GROUP, INC. | Gosin Barry M | Officer - Chief Executive Officer | Real Estate Agents & Managers (For Others) | BUY | $7.71 | 561,084 | $4,328,090 | 2,770,462 | +25.4% |
| 2019-05-14 23:31 | 2019-05-13 | MIST | Milestone Pharmaceuticals Inc. | Novo Holdings A/S | 10% owner | Pharmaceutical Preparations | BUY | $15.00 | 333,333 | $4,999,995 | 2,674,470 | +14.2% |
| 2019-05-14 23:46 | 2019-05-10 | TRGP | Targa Resources Corp. | Evans Robert B | Director | Natural Gas Transmission | BUY | $39.38 | 51,420 | $2,025,038 | 20,000 | +100.0% |
| 2019-05-15 04:52 | 2019-05-10 | N/A | Runway Growth Finance Corp. | Carilion Clinic | 10% owner | Other | BUY | $15.16 | 293,572 | $4,450,548 | 1,739,837 | +20.3% |
| 2019-05-14 23:50 | 2019-05-10 | UGI | UGI CORP /PA/ | HERMANCE FRANK S | Director | Gas & Other Services Combined | BUY | $54.10 | 100,000 | $5,410,480 | 250,000 | +66.7% |
| 2019-05-15 01:36 | 2019-05-10 | EIGI | N/A | Okumus Fund Management Ltd. | 10% owner | Other | BUY | $2.53 | 411,178 | $1,039,622 | 14,418,900 | +2.9% |
| 2019-05-15 02:41 | 2019-05-10 | EIGI | N/A | Okumus Fund Management Ltd. | 10% owner | Other | BUY | $5.15 | 411,178 | $2,117,197 | 14,418,900 | +2.9% |
| 2019-05-15 00:33 | 2019-05-13 | KMI | KINDER MORGAN, INC. | KINDER RICHARD D | Director, Officer, 10% owner - Executive Chairman | Natural Gas Transmission | BUY | $19.53 | 300,000 | $5,858,610 | 240,879,496 | +0.1% |
| 2019-05-15 01:35 | 2019-05-10 | COTY | COTY INC. | Volatier Luc | Officer - Chief Global Supply Officer | Perfumes, Cosmetics & Other Toilet Preparations | BUY | $11.51 | 451,263 | $5,194,985 | 451,263 | +100.0% |
| 2019-05-15 01:33 | 2019-05-10 | COTY | COTY INC. | Terisse Pierre-Andre | Officer - Chief Financial Officer | Perfumes, Cosmetics & Other Toilet Preparations | BUY | $11.73 | 152,000 | $1,782,732 | 152,000 | +100.0% |
| 2019-05-15 01:30 | 2019-05-10 | COTY | COTY INC. | Laubies Pierre | Director, Officer - Chief Executive Officer | Perfumes, Cosmetics & Other Toilet Preparations | BUY | $11.64 | 648,228 | $7,542,327 | 2,956,675 | +28.1% |
| 2019-05-15 01:27 | 2019-05-10 | COTY | COTY INC. | HARF PETER | Director | Perfumes, Cosmetics & Other Toilet Preparations | BUY | $11.66 | 4,675,301 | $54,493,438 | 8,599,520 | +119.1% |
| 2019-05-15 01:34 | 2019-05-14 | NS | N/A | GREEHEY WILLIAM E | Director | Other | BUY | $28.38 | 68,075 | $1,931,907 | 9,114,751 | +0.8% |
| 2019-05-14 23:54 | 2019-05-10 | UFI | UNIFI INC | ValueAct Holdings, L.P. | Director, Other | Textile Mill Products | BUY | $20.20 | 52,500 | $1,060,448 | 1,298,402 | +4.2% |
| 2019-05-14 02:32 | 2019-05-13 | NXTC | NextCure, Inc. | Xu Stella | Director | Pharmaceutical Preparations | BUY | $15.00 | 125,000 | $1,875,000 | 1,103,570 | +12.8% |
| 2019-05-14 02:32 | 2019-05-13 | NXTC | NextCure, Inc. | Khuong Chau Quang | Director | Pharmaceutical Preparations | BUY | $15.00 | 350,000 | $5,250,000 | 2,711,013 | +14.8% |
| 2019-05-13 23:24 | 2019-05-03 | BUSE | FIRST BUSEY CORP /NV/ | King Stephen V | Director | State Commercial Banks | BUY | $26.80 | 56,090 | $1,503,173 | 126,753 | +79.4% |
| 2019-05-14 00:13 | 2019-05-09 | TRVI | Trevi Therapeutics, Inc. | Makhzoumi Mohamad | 10% owner | Pharmaceutical Preparations | BUY | $10.00 | 2,500,000 | $25,000,000 | 4,438,562 | +129.0% |
| 2019-05-14 00:12 | 2019-05-09 | TRVI | Trevi Therapeutics, Inc. | Chang Carmen | 10% owner | Pharmaceutical Preparations | BUY | $10.00 | 2,500,000 | $25,000,000 | 4,438,562 | +129.0% |
| 2019-05-14 00:11 | 2019-05-09 | TRVI | Trevi Therapeutics, Inc. | Behbahani Ali | 10% owner | Pharmaceutical Preparations | BUY | $10.00 | 2,500,000 | $25,000,000 | 4,438,562 | +129.0% |
| 2019-05-14 00:10 | 2019-05-09 | TRVI | Trevi Therapeutics, Inc. | New Enterprise Associates 16, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $10.00 | 2,500,000 | $25,000,000 | 4,438,562 | +129.0% |
| 2019-05-14 00:03 | 2019-05-09 | TRVI | Trevi Therapeutics, Inc. | Omega Fund V, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $10.00 | 481,000 | $4,810,000 | 1,063,408 | +82.6% |
| 2019-05-14 00:03 | 2019-05-09 | TRVI | Trevi Therapeutics, Inc. | Mellon Family Investment Co V | 10% owner | Pharmaceutical Preparations | BUY | $10.00 | 100,000 | $1,000,000 | 347,156 | +40.5% |
| 2019-05-14 00:01 | 2019-05-09 | TRVI | Trevi Therapeutics, Inc. | Aperture Venture Partners IV, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $10.00 | 112,000 | $1,120,000 | 344,963 | +48.1% |
| 2019-05-14 00:01 | 2019-05-09 | TRVI | Trevi Therapeutics, Inc. | Agger Mette Kirstine | Director | Pharmaceutical Preparations | BUY | $10.00 | 375,000 | $3,750,000 | 1,151,544 | +48.3% |
| 2019-05-14 00:00 | 2019-05-09 | TRVI | Trevi Therapeutics, Inc. | Richard King Mellon Foundation | 10% owner | Pharmaceutical Preparations | BUY | $10.00 | 100,000 | $1,000,000 | 347,157 | +40.5% |
| 2019-05-14 00:00 | 2019-05-09 | TRVI | Trevi Therapeutics, Inc. | Lundbeckfond Invest A/S | 10% owner | Pharmaceutical Preparations | BUY | $10.00 | 375,000 | $3,750,000 | 1,151,544 | +48.3% |
| 2019-05-14 00:12 | 2019-05-09 | TRVI | Trevi Therapeutics, Inc. | Florence Anthony A. Jr. | 10% owner | Pharmaceutical Preparations | BUY | $10.00 | 2,500,000 | $25,000,000 | 4,438,562 | +129.0% |
| 2019-05-14 00:15 | 2019-05-09 | TRVI | Trevi Therapeutics, Inc. | Sonsini Peter W. | 10% owner | Pharmaceutical Preparations | BUY | $10.00 | 2,500,000 | $25,000,000 | 4,438,562 | +129.0% |
| 2019-05-14 00:15 | 2019-05-09 | TRVI | Trevi Therapeutics, Inc. | Walker Paul Edward | 10% owner | Pharmaceutical Preparations | BUY | $10.00 | 2,500,000 | $25,000,000 | 4,438,562 | +129.0% |
| 2019-05-14 00:01 | 2019-05-09 | FRGI | N/A | Jefferies Financial Group Inc. | 10% owner | Other | BUY | $13.31 | 385,153 | $5,127,157 | 4,171,774 | +10.2% |
| 2019-05-14 01:01 | 2019-05-10 | CNDT | CONDUENT Inc | ICAHN CARL C | 10% owner | Services-Business Services, NEC | BUY | $8.35 | 3,915,417 | $32,683,552 | 28,901,957 | +15.7% |
| 2019-05-14 00:11 | 2019-05-09 | TRVI | Trevi Therapeutics, Inc. | BASKETT FOREST | 10% owner | Pharmaceutical Preparations | BUY | $10.00 | 2,500,000 | $25,000,000 | 4,438,562 | +129.0% |
| 2019-05-14 00:14 | 2019-05-09 | TRVI | Trevi Therapeutics, Inc. | SANDELL SCOTT D | 10% owner | Pharmaceutical Preparations | BUY | $10.00 | 2,500,000 | $25,000,000 | 4,438,562 | +129.0% |
| 2019-05-14 00:13 | 2019-05-09 | TRVI | Trevi Therapeutics, Inc. | MAKOWER JOSHUA | 10% owner | Pharmaceutical Preparations | BUY | $10.00 | 2,500,000 | $25,000,000 | 4,438,562 | +129.0% |
| 2019-05-14 00:14 | 2019-05-09 | TRVI | Trevi Therapeutics, Inc. | MOTT DAVID M | 10% owner | Pharmaceutical Preparations | BUY | $10.00 | 2,500,000 | $25,000,000 | 4,438,562 | +129.0% |
| 2019-05-14 00:32 | 2019-05-09 | AES | AES Corporation | UBBEN JEFFREY W | Director, Other | Cogeneration Services & Small Power Producers | BUY | $16.10 | 2,582,000 | $41,581,044 | 4,146,500 | +165.0% |
| 2019-05-14 03:18 | 2019-05-13 | CWH | Camping World Holdings, Inc. | LEMONIS MARCUS | Director, Officer, 10% owner - CHIEF EXECUTIVE OFFICER | Retail-Auto Dealers & Gasoline Stations | BUY | $11.24 | 100,000 | $1,123,510 | 199,094 | +100.9% |
| 2019-05-14 00:28 | 2019-05-09 | CWH | Camping World Holdings, Inc. | ABRAMS CAPITAL MANAGEMENT, L.P. | 10% owner | Retail-Auto Dealers & Gasoline Stations | BUY | $11.98 | 525,723 | $6,298,162 | 4,884,531 | +12.1% |
| 2019-05-14 01:06 | 2019-05-09 | TRVI | Trevi Therapeutics, Inc. | TPG Group Holdings (SBS) Advisors, Inc. | 10% owner | Pharmaceutical Preparations | BUY | $10.00 | 800,000 | $8,000,000 | 6,573,000 | +13.9% |
| 2019-05-14 02:32 | 2019-05-13 | NXTC | NextCure, Inc. | ORBIMED ADVISORS LLC | Director, 10% owner | Pharmaceutical Preparations | BUY | $15.00 | 350,000 | $5,250,000 | 2,711,013 | +14.8% |
| 2019-05-13 17:50 | 2019-05-10 | KMI | KINDER MORGAN, INC. | KINDER RICHARD D | Director, Officer, 10% owner - Executive Chairman | Natural Gas Transmission | BUY | $19.43 | 177,542 | $3,449,091 | 240,579,496 | +0.1% |
| 2019-05-13 20:28 | 2019-05-09 | GEL | GENESIS ENERGY LP | JASTROW KENNETH M II | Director | Pipe Lines (No Natural Gas) | BUY | $21.54 | 50,000 | $1,077,040 | 100,000 | +100.0% |
| 2019-05-14 00:11 | 2019-05-09 | TRVI | Trevi Therapeutics, Inc. | BARRIS PETER J | 10% owner | Pharmaceutical Preparations | BUY | $10.00 | 2,500,000 | $25,000,000 | 4,438,562 | +129.0% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.